Skip to main content
SpringerLink
Log in

Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

This study determined the effect of pinacidil on the concentration of plasma lipids and apolipoproteins in male patients previously equilibrated with 25 mg hydrochlorothiazide twice daily.

Pinacidil therapy given to 52 hypertensives at 25 to 100 mg daily for 8 weeks resulted in a reduction of systolic and diastolic blood pressure concurrently to reductions in plasma cholesterol and triglycerides with no change in low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C). There was an associated decrease in apolipoproteins (Apo)B, C-III and E and elevation in ApoA-I. A parallel placebo group of 44 patients experienced reduction in diastolic blood pressure and an elevation in ApoA-I.

These changes indicate that pinacidil will be a useful antihypertensive agent having properties on lipoprotein metabolism which would favor decreased risks of atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arrigoni-Martelli E, Kaergaard Nielsen C, Bang Olsen U, Peterson HJ (1980) N''-cyano-N-4-pyridyl-N'-1,2,2 trimethyl-propylguanidine, monohydrate (P1134): A new, potent vasodilator. Experientia 36: 445–447

    Google Scholar 

  2. Byyny RL, Nies AS, LaVerde ME, Mitchell WD (1987) A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension. Clin Pharmacol Ther 42: 50–57

    Google Scholar 

  3. Goldberg MR, Sushak MS, Rockhold FW, Thompson WL (1988) Vasodilator monotherapy in the treatment of hypertension: Comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin. Clin Pharmacol Ther 44: 78–92

    Google Scholar 

  4. Goldberg MR, Rockhold FW, Offen WW, Dornseif BE (1989) Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension. Clin Pharmacol Ther 46: 208–218

    Google Scholar 

  5. Goldberg MR, Rockhold FW, Thompson WL, DeSante KA (1989) Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension. J Clin Pharmacol 29: 33–40

    Google Scholar 

  6. Southerton JS, Weston AH, Bray KM, Newgreen DT, Taylor SG (1988) The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. Naunyn Schmiedebergs Arch Pharmacol 338: 310–318

    Google Scholar 

  7. Quasthoff S, Spuler A, Lehmann-Horn F, Grafe P (1989) Cromakalim, pinacidil and RP 49356 activate a tolbutamide-sensitive K + conductance in human skeletal muscle fibres. Pflugers Arch 414: S179-S180

    Google Scholar 

  8. Arena JP, Kass RS (1989) Enhancement of potassium-sensitive current in heart cells by pinacidil. Evidence for modulation of the ATP-sensitive potassium channel. Circ Res 65: 436–445

    Google Scholar 

  9. Woodcock BG, Reitbrock N (1984) Beta-blocker induced charges in the cholesterol: high-density lipoprotein cholesterol ratio and risk of coronary heart disease. Klin Wochenschr 62: 843–849

    Google Scholar 

  10. Weinberger MH (1986) Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular risk. Am J Med 80: S64-S70

    Google Scholar 

  11. Rockhold FW, Goldberg MR, Thompson WL et al. (1989) Beneficial effects of pinacidil on blood lipids: Comparisons with prazosin and placebo in patients with hypertension. J Lab Clin Med 114: 646–654

    Google Scholar 

  12. Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19: 476–482

    Google Scholar 

  13. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470–475

    Google Scholar 

  14. Manual of Laboratory Operations, Lipid Research Clinics Program. Lipid and Lipoprotein Analysis. DHEW Pub. No. (NIH) 75–628, pp. 71–74, 1974

  15. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol, without use of the preparative ultracentrifuge. Clin Chem 18: 499–502

    Google Scholar 

  16. Curry MD, Alaupovic P, Suenram CA (1976) Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem 22: 315–322

    Google Scholar 

  17. Curry MD, Gustafson A, Alaupovic P, McConathy WJ (1978) Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem 24: 280–286

    Google Scholar 

  18. Curry MD, McConathy WJ, Fesmire JD, Alaupovic P (1980) Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta 617: 503–513

    Google Scholar 

  19. Curry MD, McConathy WJ, Alaupovic P, Ledford JH, Popovic M (1976) Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta 439: 413–425

    Google Scholar 

  20. Cham BE, Knowles BR (1976) A solvent system for delipidization of plasma or serum without protein precipitation. J Lipid Res 17: 176–181

    Google Scholar 

  21. SAS Institute (1985) SAS Users Guide: Basics, 5th ed. Cary, NC: SAS Institute

    Google Scholar 

  22. Johnson BF (1982) The emerging problem of plasma lipid changes during antihypertensive therapy. J Cardiovasc Pharmacol 4: S213-S221

    Google Scholar 

  23. Cutler R (1982) Effect of antihypertensive agents on lipid metabolism. Am J Cardiol 51: 628–631

    Google Scholar 

  24. Corder CN, Goldberg MR, Alaupovic P, Price MD (1988) Apolipoprotein levels in hypertensive patients receiving hydrochlorothiazide. Atherosclerosis 8: 589a-590b

    Google Scholar 

  25. Alaupovic P, McConathy WJ, Fesmire J, Tavella M, Bard JM (1988) Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias. Clin Chem 33: B13-B27

    Google Scholar 

  26. Grundy SM, Vega GL (1990) Role of apolipoprotein levels in clinical practice. Arch Intern Med 150: 1579–1582

    Google Scholar 

  27. Wang CS, McConathy WJ, Kloer HU, Alaupovic P (1985) Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75: 384–390

    Google Scholar 

  28. Blankenhorn DH, Alaupovic P, Wickham MS, Chin HP, Azen SP (1990) Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 81: 470–476

    Google Scholar 

  29. Keys A, Menott A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, Mohacek I, Nedeljkovic S, Puddu V, Punsar S, Taylor HL, Conti S, Kromhout D, Toshima H (1984) The Seven Countries Study: 2,289 Deaths in 15 years. Prev Med 13: 141–154

    Google Scholar 

  30. Bachorik PS, Kwiterovich PO (1988) Apoliprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays. Clin Chim Acta 178: 1–34

    Google Scholar 

  31. Corder CN, Goldberg MR, Alaupovic PA, Price MD (1989) Lipoprotein changes during therapy with pinacidil. Clin Pharmacol Ther 45: 184

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oklahoma Medical Research Foundation, Oklahoma City, USA

    C. N. Corder, P. A. Alaupovic & M. D. Price

  2. Eli Lilly Co., Indianapolis, USA

    M. R. Goldberg & S. S. Furste

Authors
  1. C. N. Corder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. R. Goldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. A. Alaupovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. D. Price
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. S. Furste
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corder, C.N., Goldberg, M.R., Alaupovic, P.A. et al. Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide. Eur J Clin Pharmacol 42, 65–70 (1992). https://doi.org/10.1007/BF00314922

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314922

Key words

Search

Navigation